Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Epidermal growth factor helps hair stem cells grow by activating specific cell pathways.

Cetuximab can cause excessive eyelash growth.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Gefitinib can cause hair loss without scarring.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Overexpressing the epigen gene in mice leads to enlarged sebaceous glands and greasy fur.

Erlotinib can cause nonscarring hair loss and itchy skin.

Erlotinib may cause scarring hair loss.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Cetuximab can cause eyelash growth, which is rare but manageable.

New cancer drugs often cause skin and nail problems.

Tideglusib helps heal wounds in older skin.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Erlotinib can cause hair loss as a side effect.

Reducing gefitinib dosage improved hair loss, but scarring remained.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

EGFR inhibitors can cause yellowish skin eruptions.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Activating Nrf2 in skin cells speeds up wound healing by increasing the growth of certain stem cells.

TACE/ADAM17 is essential for maintaining healthy hair and hair follicle stem cells.

Sema3A can both slow and speed up wound healing, depending on its form and combination with EGF.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

EGFR helps mouse hair follicles stop growing by reducing certain growth regulators.

ILK and ELMO2 help cells move and stick together, important for wound healing and hair growth.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.